Cloud-clone
SKU:MAK032Hu21
Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)
Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)
Couldn't load pickup availability
Western blotting: 0.5-5µg/mL
Immunohistochemistry: 5-30µg/mL
Immunocytochemistry: 5-30µg/mL
Optimal working dilutions must be determined by end user.
Product No.
MAK032Hu21
Organism Species
Homo sapiens (Human).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
6#
Ig Isotype
N/A
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPK032Hu01-Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
Mus musculus (Mouse), Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against VTCN1. It has been selected for its ability to recognize VTCN1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| International Journal of Clinical Oncology | Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance Pubmed:24804867 |
| Iranian Journal of Immunology | Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus. Pubmed: 30864554 |
Share
